BELLUS Health Inc. Income Statement

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Revenues
Expenses:
Research and development
Research tax credits
Research and development, net of tax credits
General and administrative
Total operating expenses
Loss from operating activities
Finance income
Finance costs
Net finance income
Loss before income taxes
Income tax expense (recovery)
Net loss and total comprehensive loss for the year
Other comprehensive income:
Currency translation adjustment (note 2 (c))
Other comprehensive income for the year
Total comprehensive loss for the year

Basic and diluted loss per share
Loss per share
Basic loss per share
Diluted loss per share

Comments